<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=MCM4</id>
	<title>MCM4 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=MCM4"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=MCM4&amp;action=history"/>
	<updated>2026-04-09T19:18:07Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=MCM4&amp;diff=4701&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21) [CDC21]  ==Publications==  {{medline-entry |title=Hepatoprotective effects of hydro...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=MCM4&amp;diff=4701&amp;oldid=prev"/>
		<updated>2021-04-29T19:30:35Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21) [CDC21]  ==Publications==  {{medline-entry |title=Hepatoprotective effects of hydro...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21) [CDC21]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Hepatoprotective effects of hydroxysafflor yellow A in D-galactose-treated aging mice.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32454116&lt;br /&gt;
|abstract=Hydroxysafflor yellow A (HSYA) is an effective chemical component isolated from Chinese herb Carthamus tinctorius L. In present study, we aimed to evaluate the effects of HSYA on D-galactose- (D-gal-) induced aging in mice, and to elucidate the underlying mechanism. Male C57BL/6 mice were intraperitoneal injection of D-gal and HSYA for 8 weeks. The body weight gain, spleen and thymus coefficients were determined. Levels of super dismutase (SOD), catalase ([[CAT]]), glutathione peroxidase (GSH-Px) and malondialdehyde (MDA) in serum and liver were measured using commercial kits. Pathological changes and the SA-β-Gal activity in liver tissues were detected by hematoxylin and eosin and SA-β-Gal staining. The expression levels of p16, [[CDK4]], [[CDK6]] and phosphorylation levels of Retinoblastoma (Rb) were detected by immunohistochemistry and western blot analysis. mRNA levels of genes regulated by p16-Rb pathway were determined by quantitative real-time PCR. In vivo, HSYA improved the aging changes including body weight, organ index and antioxidant status such as activities of SOD, [[CAT]], GSH-Px and MDA in D-gal treated aging mice. HSYA also dramatically attenuated pathologic changes of aging liver tissues induced by D-gal. Furthermore, HSYA significantly decreased the mRNA and protein level of cyclin-dependent kinase inhibitor p16, followed by increasing [[CDK4]]/6 protein expression and decreasing the phosphorylation of Retinoblastoma (pRb) which up-regulated the expression of downstream genes [[CCNE1]], [[CCNA2]], P107 and [[MCM4]]. Collectively, these data indicated that HSYA could ameliorate aging, especially hepatic replicative senescence resulting from D-gal, the mechanism could be associated with the suppression of p16-Rb pathway.&lt;br /&gt;
&lt;br /&gt;
|keywords=* D-galactose&lt;br /&gt;
* Hydroxysafflor yellow A&lt;br /&gt;
* Oxidative stress&lt;br /&gt;
* Replicative senescence&lt;br /&gt;
* p16&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1016/j.ejphar.2020.173214&lt;br /&gt;
}}&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Changes in [[MCM2]]-7 proteins at senescence.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31092751&lt;br /&gt;
|abstract=Cellular aging is characterized by the loss of DNA replication capability and is mainly brought about by various changes in chromatin structure. Here, we examined changes in [[MCM2]]-7 proteins, which act as a replicative DNA helicase, during aging of human WI38 fibroblasts at the single-cell level. We used nuclear accumulation of p21 as a marker of senescent cells, and examined changes in [[MCM2]]-7 by western blot analysis. First, we found that senescent cells are enriched for cells with a DNA content higher than 4N. Second, the levels of [[MCM2]], [[MCM3]], [[MCM4]] and [[MCM6]] proteins decreased in senescent cells. Third, cytoplasmic localization of [[MCM2]] and [[MCM7]] was observed in senescent cells, from an analysis of [[MCM2]]-7 except for [[MCM5]]. Consistent with this finding, fragmented [[MCM2]] was predominant in these cells. These age-dependent changes in [[MCM2]]-7, a protein complex that directly affects cellular DNA replication, may play a critical role in cellular senescence.&lt;br /&gt;
|mesh-terms=* Cell Cycle Proteins&lt;br /&gt;
* Cellular Senescence&lt;br /&gt;
* DNA Replication&lt;br /&gt;
* Gene Expression Regulation&lt;br /&gt;
* Humans&lt;br /&gt;
* Minichromosome Maintenance Complex Component 2&lt;br /&gt;
* Minichromosome Maintenance Complex Component 3&lt;br /&gt;
* Minichromosome Maintenance Complex Component 4&lt;br /&gt;
* Minichromosome Maintenance Complex Component 6&lt;br /&gt;
* Minichromosome Maintenance Complex Component 7&lt;br /&gt;
* Multiprotein Complexes&lt;br /&gt;
* Single-Cell Analysis&lt;br /&gt;
* p21-Activated Kinases&lt;br /&gt;
|keywords=* DNA content&lt;br /&gt;
* MCM2–7 proteins&lt;br /&gt;
* cellular aging&lt;br /&gt;
* cellular localization&lt;br /&gt;
* protein degradation&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1266/ggs.18-00062&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>